N
CGEM icon

Nuveen’s Cullinan Oncology CGEM Stock Holding History

Nuveen’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4M Buy
805,700
+226,605
+39% +$2.91M ﹤0.01% 1467
2025
Q4 		$5.99M Buy
579,095
+363,500
+169% +$3.28M ﹤0.01% 1828
2025
Q3 		$1.28M Buy
215,595
+34,910
+19% +$256K ﹤0.01% 2502
2025
Q2 		$1.36M Sell
180,685
-7,345
-4% -$59K ﹤0.01% 2464
2025
Q1 		$1.42M Sell
188,030
-39,003
-17% -$374K ﹤0.01% 2478
2024
Q4 		$2.77M Sell
227,033
-6,533
-3% -$93.9K ﹤0.01% 2248
2024
Q3 		$3.91M Buy
233,566
+15,800
+7% +$280K ﹤0.01% 2102
2024
Q2 		$3.8M Buy
217,766
+124,544
+134% +$2.65M ﹤0.01% 2083
2024
Q1 		$1.59M Buy
93,222
+4,899
+6% +$75.7K ﹤0.01% 2500
2023
Q4 		$900K Buy
88,323
+9,707
+12% +$86K ﹤0.01% 2782
2023
Q3 		$711K Buy
78,616
+1,305
+2% +$13.6K ﹤0.01% 2717
2023
Q2 		$832K Buy
77,311
+5,103
+7% +$54.2K ﹤0.01% 2732
2023
Q1 		$739K Sell
72,208
-20,548
-22% -$227K ﹤0.01% 2708
2022
Q4 		$978K Sell
92,756
-14,604
-14% -$177K ﹤0.01% 2687
2022
Q3 		$1.38M Buy
107,360
+1,347
+1% +$18.1K ﹤0.01% 2588
2022
Q2 		$1.36M Sell
106,013
-1,455
-1% -$16.5K ﹤0.01% 2642
2022
Q1 		$1.38M Sell
107,468
-8,496
-7% -$115K ﹤0.01% 2682
2021
Q4 		$1.79M Sell
115,964
-77,228
-40% -$1.54M ﹤0.01% 2620
2021
Q3 		$4.36M Buy
193,192
+69,822
+57% +$1.87M ﹤0.01% 2285
2021
Q2 		$3.18M Buy
123,370
+73,634
+148% +$2.26M ﹤0.01% 2486
2021
Q1 		$2.07M Buy
+49,736
New +$2.02M ﹤0.01% 2599

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return